ArticleScientific reports2024

Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells.

A Markovska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.